← Back to Search

Behavioral Intervention

Cognitive Rehabilitation for Cognitive Issues After Heart Transplant

N/A
Waitlist Available
Led By Susan Hiniker
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients must have a histologic or cytological diagnosis of ALL treated with stem cell transplantation. There are no restrictions on prior therapy.
Patient and/or parents/guardians as appropriate must sign an informed consent, be mentally responsible, able to understand and willing to sign a written informed consent.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how well a new iPad-based treatment works for people with cognitive problems after a heart transplant.

Who is the study for?
This trial is for children and young adults aged 6 to 21 with Acute Lymphoblastic Leukemia (ALL) who have undergone stem cell transplantation. Participants must be able to understand and consent to the study, or have guardians who can. There are no limits on previous treatments, but pregnant individuals or those with serious medical issues that could interfere with the trial cannot join.
What is being tested?
The study tests an iPad-based cognitive rehabilitation program designed for pediatric patients recovering from a stem cell transplant due to ALL. The focus is on how feasible it is for participants to follow this program and how their brain function scores change after treatment and over time.
What are the potential side effects?
Since this intervention involves cognitive exercises using an iPad, there are no direct physical side effects like you'd expect from medication. However, fatigue or frustration may occur if tasks become challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have ALL and have been treated with a stem cell transplant.
Select...
I (or my guardian) understand and agree to participate in the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive rehabilitation armExperimental Treatment1 Intervention
Cognitive rehabilitation program
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive rehabilitation program
2015
N/A
~80

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,468 Previous Clinical Trials
17,496,247 Total Patients Enrolled
Susan HinikerPrincipal InvestigatorStanford University
~4 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top